Xvivo Perfusion AB (publ) (LON:0RKL)
176.05
+2.26 (1.30%)
At close: Sep 17, 2025
Xvivo Perfusion AB Employees
Xvivo Perfusion AB had 190 employees as of December 31, 2024. The number of employees increased by 30 or 18.75% compared to the previous year.
Employees
190
Change (1Y)
30
Growth (1Y)
18.75%
Revenue / Employee
327.28K GBP
Profits / Employee
44.29K GBP
Market Cap
438.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 190 | 30 | 18.75% |
Dec 31, 2023 | 160 | 20 | 14.29% |
Dec 31, 2022 | 140 | 27 | 23.89% |
Dec 31, 2021 | 113 | 31 | 37.80% |
Dec 31, 2020 | 82 | 42 | 105.00% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Xvivo Perfusion AB News
- 2 months ago - Xvivo Perfusion AB (XVIPF) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - GuruFocus
- 2 months ago - Q2 2025 Xvivo Perfusion AB Earnings Call Transcript - GuruFocus